NABEN
Live / Registered — Registered (as of 23 Feb 2021)
What this means for you
Registered since 23 Feb 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88087944
- Registration number
- 6274912
- Mark type
- Stylized text
- Filed
- 22 Aug 2018
- Published for opposition
- 08 Dec 2020
- Registered
- 23 Feb 2021
- Attorney of record
- Michael T. Smith
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical for the treatment of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Chemical reagents for medical or veterinary purposes; Sodium salts for medical purposes
Owner
- SYNEURX NEUROSCIENCE, GRAND CAYMAN, KY
- SyneuRx International (Taiwan) Corp., New Taipei City, TW
- SyneuRx International (Taiwan) Corp., New Taipei City, TW
- SyneuRx International (Taiwan) Corp., New Taipei City, TW
Prosecution history
- 23 Feb 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Jan 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 23 Feb 2021 — REGISTERED-PRINCIPAL REGISTER
- 08 Dec 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Dec 2020 — PUBLISHED FOR OPPOSITION
- 18 Nov 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Oct 2020 — 1(B) BASIS DELETED; NEW BASIS REQUESTED
- 30 Oct 2020 — NOTICE OF ALLOWANCE CANCELLED
- 30 Oct 2020 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 29 Oct 2020 — ASSIGNED TO PETITION STAFF
- 12 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2020 — SOU EXTENSION 3 GRANTED
- 10 Sept 2020 — SOU EXTENSION 3 FILED
- 10 Sept 2020 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2020 — TEAS PETITION TO AMEND BASIS RECEIVED